NB-9402

Asset

Covalent irreversible allosteric small-molecule SARM1 inhibitor preventing axonal degeneration

Stage
Phase 1
Modality
Small molecule
Target
NAD+ metabolism
0
Indications
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains2
  • Owner and partners1
  • Evidence for its targets2
  • Competitors2

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets